AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.

This product is a competitive ELISA-like kit using a recombinant Hyaluronic Acid Binding Protein (rHABP) optimized to quantify HA polymers of average molecular weight greater than 7.4 kDa in samples such as serum, plasma and culture supernatant.

Hyaluronic Acid (HA) is a Glycosaminoglycan (GAG) with a simple structure that is widely found in the extracellular matrix, and abundant in synovial fluid, skin, umbilical cord, and vitreous bodies; contributing to tissue water retention and to cellular growth, differentiation, and migration. Because of its simplicity and ubiquity, HA is not immunogenic so classical immunological analysis has not been possible.

Recombinant HABP specifically detects Hyaluronic Acid (HA), binding to HA from all species and tissues. It does not cross-react with other GAG’s or to DNA. Recombinant production means that rHABP offers intrinsically higher safety compared with animal-derived HABP.

For further information on the new Hyaluronic Acid Quantification Kit please visit http://www.amsbio.com/Proteoglycans-Glycosaminoglycans-HABP.aspx or contact AMSBIO on +44-1235-828200/ +1-617-945-5033 / [email protected].

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.